Episode 26 - Kyle Felmet, Jennifer Lospinoso and the Art of Efficient Commercial Product Launch

The Future of Pharma

I have two guests in today's episode, something I rarely do. My guests are Kyle Felmet and Jennifer Lospinoso.

Kyle Felmet serves as the Vice President of Specialty Commercialization at Two Labs, an Envision Pharma Company, where he plays a pivotal role in ensuring that specialty drug manufacturers have the necessary distribution channel strategy infrastructure and pre-launch workstreams in place to facilitate a successful product launch with the appropriate wrap-around patient/prescriber services tailored to each unique product. His expertise spans across key therapeutic areas including oncology, rare diseases, and cell and gene therapies. Over the past decade, Kyle has been instrumental in supporting clients and vendors within these sectors, leading several successful product launches.

Jennifer Lospinoso is the Managing Director & Consulting Lead at Riparian. Jennifer brings 20 years of leadership experience in various areas of government and commercial program operations and compliance. Jennifer has extensive experience leading and delivering projects focused on U.S. government program regulatory compliance, gross-to-net forecasting and operational excellence.

In this wide-ranging talk, Kyle, Jennifer and I talk about - Cell and gene therapy (CGT) pricing in the absence of insufficient historical data - The challenges to set a price for CGT by the government and insurance companies - Justification for high prices for CGT - Outcome based reimbursements - Expensive distribution logistics for CGT - Why the product launch preparation starts 24-36 months before the actual launch date - What start ups can do during the early phase to make product launch efficient and cost effective and - Their favorite books and topics for their potential TedTalks.

This was an interesting discussion for me because we talked about where the science ends and the commercialization begins, something I haven't done.

I enjoyed my chat with Kyle and Jenn. Hope you do to.

Here's Kyle Felmet and Jennifer Lospinoso.